'Turning point' in fight against Alzheimer's: Scientists hail drug made by Eli Lilly that slows early stage of disease by up to 60% as 'defining moment' in dementia research

It is the second treatment to offer hope to patients in what experts have hailed 'the decade of dementia' which could see it likened to other conditions such as asthma. A US roll out could happen in 18 months.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news